01374nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002600112020001800138020001800156020002700174040002100201035002100222050002700243082002000270245010500290260003600395300005700431490005100488504005100539533015200590650002800742650004000770650002200810655002900832700002000861710001700881856012600898ebr10494542CaPaEBRm        u        cr cn|||||||||101008s2011    njuaf   sb    001 0 eng d  z  2010043285  z9780470184745 (cloth)  z9781118015377  z9781118015360  z9781118015353 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)75782733214aQR201.A37bH547 2011eb04a616.97/920122200aHIV-1 integraseh[electronic resource] :bmechanism and inhibitor design /cedited by Nouri Neamati.  aHoboken, N.J. :bWiley,cc2011.  axiii, 506 p., [15] p. of plates :bill. (some col.).0 aWiley series on drug discovery and development  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2011.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aHIV (Viruses)xEnzymes. 0aHIV (Viruses)xEnzymesxInhibitors. 0aAntiviral agents. 7aElectronic books.2local1 aNeamati, Nouri.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10494542zAn electronic book accessible through the World Wide Web; click to view